Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]

P. Rosenstiel, J. Agnholt, J. Kelsen, V. Medici, G. H. Waetzig, D. Seegert, S. Schreiber, A. Di Sabatino, R. Ciccocioppo, R. Morera, G. R. Corazza

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)314-316
Number of pages3
Issue number2
Publication statusPublished - Feb 2005

ASJC Scopus subject areas

  • Gastroenterology

Cite this